Inner Mongolia Furui Med Sci (300049) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.06 Million ≈ $20.35 Million USD) by net assets (CN¥2.79 Billion ≈ $407.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Inner Mongolia Furui Med Sci to measure how much of total assets are equity-financed.
Inner Mongolia Furui Med Sci - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Inner Mongolia Furui Med Sci's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Inner Mongolia Furui Med Sci (300049) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Inner Mongolia Furui Med Sci Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DRDGOLD Limited
F:DUBA
|
0.066x |
|
Storskogen Group AB Series B
ST:STOR-B
|
0.056x |
|
AOZORA BANK LTD ADR/20
F:AON0
|
N/A |
|
SUEDZUCKER UNSP.ADR 1/2
F:SZU1
|
-0.001x |
|
Mercuries Life Insurance Co Ltd
TW:2867
|
-0.072x |
|
Flywire Corp
NASDAQ:FLYW
|
-0.019x |
|
Punjab & Sind Bank
NSE:PSB
|
-0.594x |
|
Gansu Shangfeng Cement Co Ltd
SHE:000672
|
0.031x |
Annual Cash Flow Conversion Efficiency for Inner Mongolia Furui Med Sci (2006–2025)
The table below shows the annual cash flow conversion efficiency of Inner Mongolia Furui Med Sci from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Inner Mongolia Furui Med Sci (300049) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.79 Billion ≈ $407.78 Million |
CN¥354.15 Million ≈ $51.82 Million |
0.127x | +22.14% |
| 2024-12-31 | CN¥2.13 Billion ≈ $311.38 Million |
CN¥221.41 Million ≈ $32.40 Million |
0.104x | -36.95% |
| 2023-12-31 | CN¥1.85 Billion ≈ $270.33 Million |
CN¥304.89 Million ≈ $44.61 Million |
0.165x | +59.05% |
| 2022-12-31 | CN¥1.83 Billion ≈ $267.18 Million |
CN¥189.46 Million ≈ $27.72 Million |
0.104x | -15.81% |
| 2021-12-31 | CN¥1.81 Billion ≈ $264.23 Million |
CN¥222.55 Million ≈ $32.57 Million |
0.123x | -0.52% |
| 2020-12-31 | CN¥1.62 Billion ≈ $236.40 Million |
CN¥200.15 Million ≈ $29.29 Million |
0.124x | -24.98% |
| 2019-12-31 | CN¥1.55 Billion ≈ $227.04 Million |
CN¥256.23 Million ≈ $37.49 Million |
0.165x | +219.10% |
| 2018-12-31 | CN¥1.51 Billion ≈ $221.53 Million |
CN¥78.35 Million ≈ $11.46 Million |
0.052x | -24.72% |
| 2017-12-31 | CN¥1.92 Billion ≈ $280.39 Million |
CN¥131.72 Million ≈ $19.27 Million |
0.069x | -15.69% |
| 2016-12-31 | CN¥1.83 Billion ≈ $267.13 Million |
CN¥148.84 Million ≈ $21.78 Million |
0.082x | -14.91% |
| 2015-12-31 | CN¥1.65 Billion ≈ $241.53 Million |
CN¥158.16 Million ≈ $23.14 Million |
0.096x | +72.35% |
| 2014-12-31 | CN¥915.10 Million ≈ $133.91 Million |
CN¥50.88 Million ≈ $7.44 Million |
0.056x | +47.66% |
| 2013-12-31 | CN¥748.53 Million ≈ $109.53 Million |
CN¥28.18 Million ≈ $4.12 Million |
0.038x | -67.84% |
| 2012-12-31 | CN¥733.64 Million ≈ $107.35 Million |
CN¥85.88 Million ≈ $12.57 Million |
0.117x | +8.65% |
| 2011-12-31 | CN¥703.08 Million ≈ $102.88 Million |
CN¥75.75 Million ≈ $11.08 Million |
0.108x | +50.54% |
| 2010-12-31 | CN¥687.42 Million ≈ $100.59 Million |
CN¥49.20 Million ≈ $7.20 Million |
0.072x | +637.68% |
| 2009-12-31 | CN¥157.46 Million ≈ $23.04 Million |
CN¥-2.10 Million ≈ $-306.69K |
-0.013x | -105.09% |
| 2008-12-31 | CN¥139.52 Million ≈ $20.42 Million |
CN¥36.47 Million ≈ $5.34 Million |
0.261x | +87.15% |
| 2007-12-31 | CN¥127.76 Million ≈ $18.70 Million |
CN¥17.85 Million ≈ $2.61 Million |
0.140x | -64.88% |
| 2006-12-31 | CN¥124.50 Million ≈ $18.22 Million |
CN¥49.52 Million ≈ $7.25 Million |
0.398x | -- |
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liv… Read more